Massimo Breccia
Impact in
- Hematology top 0.05%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 613
- Chronic Myeloid Leukemia Treatments 424
- Acute Myeloid Leukemia Research 231
- Genetics 441
- Chronic Lymphocytic Leukemia Research 268
- Myeloproliferative Neoplasms: Diagnosis and Treatment 159
- Co-authors
- Giuliana Alimena (163 shared papers)Roberto Latagliata (155 shared papers)Francesco Lo‐Coco (37 shared papers)Matteo Molica (49 shared papers)Franco Mandelli (43 shared papers)Ida Carmosino (86 shared papers)Daniela Diverio (59 shared papers)Laura Cannella (48 shared papers)
- Journals
- Blood (106 papers)Leukemia Research (71 papers)Annals of Hematology (57 papers)British Journal of Haematology (38 papers)Leukemia (37 papers)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Massimo Breccia
689 papers receiving 14.0k citations
Massimo Breccia's Hit Papers
Peers
Comparison fields: 5 of 132
- Hematology 10.2k
- Genetics 5.6k
- Rheumatology 2.4k
- Biochemistry 589
- Oncology 1.7k
Countries citing papers authored by Massimo Breccia
This map shows the geographic impact of Massimo Breccia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Breccia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Breccia more than expected).
Fields of papers citing papers by Massimo Breccia
This network shows the impact of papers produced by Massimo Breccia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Breccia. The network helps show where Massimo Breccia may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Breccia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 727 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia Hit paper breakdown → | 2013 | 1262 |
| 2 | European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia Hit paper breakdown → | 2016 | 404 |
| 3 | Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure Hit paper breakdown → | 2019 | 365 |
| 4 | 2016 | 308 | |
| 5 | 2010 | 268 | |
| 6 | 2011 | 226 | |
| 7 | 2009 | 173 | |
| 8 | 2002 | 156 | |
| 9 | 2019 | 134 | |
| 10 | 2013 | 124 | |
| 11 | 2002 | 109 | |
| 12 | 2013 | 109 | |
| 13 | 2015 | 105 | |
| 14 | 2011 | 100 | |
| 15 | 2006 | 99 | |
| 16 | 2004 | 98 | |
| 17 | 2012 | 95 | |
| 18 | 2004 | 91 | |
| 19 | 2018 | 89 | |
| 20 | 2008 | 81 |
About Massimo Breccia
Massimo Breccia is a scholar working on Hematology, Genetics, Rheumatology, Public Health, Environmental and Occupational Health and Oncology, having authored 727 papers that have together received 14.3k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (424 papers), Chronic Lymphocytic Leukemia Research (268 papers), Acute Myeloid Leukemia Research (231 papers), Eosinophilic Disorders and Syndromes (166 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (159 papers), Retinoids in leukemia and cellular processes (75 papers), Acute Lymphoblastic Leukemia research (64 papers) and HER2/EGFR in Cancer Research (38 papers). The work is most often cited by research in Hematology (10.2k citations), Genetics (5.6k citations), Rheumatology (2.4k citations), Biochemistry (589 citations) and Oncology (1.7k citations). Massimo Breccia has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Giuliana Alimena, Roberto Latagliata, Francesco Lo‐Coco, Matteo Molica, Franco Mandelli, Ida Carmosino, Daniela Diverio, Laura Cannella, Robin Foà and Michele Baccarani. Their work appears in journals such as Blood, Leukemia Research, Annals of Hematology, British Journal of Haematology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.